Acumen Pharmaceuticals, Inc. ABOS
2.24
0.00
0.00%
as of 25 Sep
- Market cap
- $161.6M
- P/E
- 0.0×
Follow ABOS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
P/S ratio |
— | — | — | — | — | 6.05 | 6.05 | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
P/Operating CF |
— | — | — | — | — | (2.04) | (2.04) | — |
P/B ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
Price to Tangible BV |
— | — | — | — | — | 0.00 | 0.00 | — |
EV/Sales |
— | — | — | — | — | (41.87) | (41.87) | — |
EV/EBITDA |
— | — | — | — | — | 5.43 | 5.43 | — |
EV/Operating CF |
— | — | — | — | — | 5.58 | 5.58 | — |
EV/FCF |
— | — | — | — | — | 5.58 | 5.58 | — |
Quick Ratio |
3.89 | 6.21 | 18.77 | 22.73 | 37.74 | 46.00 | 8.60 | — |
Current Ratio |
4.07 | 6.46 | 19.01 | 23.08 | 38.60 | 46.57 | 9.38 | — |
Net Debt/EBITDA |
0.69 | 1.20 | 3.33 | 3.98 | 10.00 | 5.53 | 0.84 | — |
Debt/Assets |
25.37% | 12.31% | 9.64% | 0.05% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.44 | 0.16 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.46 | — |
Operating CF/Net income |
0.95 | 0.84 | 0.82 | 0.82 | 0.18 | 1.02 | 0.89 | — |
Capex/Depreciation |
0.14 | 0.00 | 0.01 | (0.25) | (0.25) | — | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (96.20%) | (45.60%) | (22.98%) | (20.71%) | (97.40%) | 48.82% | 51.22% | — | |
| (67.07%) | (37.27%) | (20.67%) | (20.08%) | (73.23%) | (28.31%) | (209.94%) | — | |
ROIC |
0.00% | (179.60%) | (71.63%) | (250.76%) | (39.55%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(131.54%) | (67.90%) | (22.40%) | (24.82%) | (51.98%) | (16.85%) | (119.85%) | — |
Average Days of Receivables |
— | — | — | — | — | 27.71 | 6.45 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 556.89% | 505.36% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 94.08% | 54.57% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.72% | 10.25% | — |
Graham Net Nets |
— | — | — | — | — | (12.49) | (12.49) | — |
Graham Number |
— | — | — | — | — | 132.11 | 0.00 | — |
Earnings Yield |
— | — | — | — | — | (1,065.13%) | (1,065.13%) | — |
Free Cash Flow Yield |
— | — | — | — | — | (124.08%) | (124.08%) | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.43 | 3.94 | — |
Operating CF per Share |
(1.91) | (1.44) | (0.89) | (0.87) | (0.90) | (17.78) | (15.83) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(1.91) | (1.44) | (0.89) | (0.87) | (0.90) | (17.78) | (15.83) | — |
Cash per Share |
1.93 | 2.86 | 5.01 | 4.37 | 9.68 | 104.48 | 15.21 | — |
Shareholders Equity per Share |
1.16 | 3.03 | 5.49 | 4.65 | 11.23 | (44.37) | (26.51) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.16 | 3.03 | 5.49 | 4.65 | 11.23 | (44.37) | (26.51) | — |
Free Cash Flow |
(115.63) | (86.23) | (43.08) | (35.31) | (18.00) | (7.45) | (6.82) | — |
Working Capital |
92.25 | 150.70 | 233.64 | 172.52 | 193.51 | 43.48 | 6.41 | — |
Capital Expenditures |
(0.09) | (0.02) | (0.02) | (0.16) | (0.04) | — | — | — |
Net Current Asset Value |
69.85 | 121.13 | 203.46 | 172.52 | 193.51 | (18.59) | (11.56) | — |
EV/EBIT |
— | — | — | — | — | 5.43 | 5.43 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (510.10%) | (452.92%) | — |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | (24.07) | 3.98 | 4.42 | — | — | — |
Cash ROIC |
(52.89%) | (22.52%) | (7.99%) | (9.64%) | (4.29%) | (29.58%) | 140.06% | — |
Accounts Receivable Turnover |
— | — | — | — | — | 20.66 | 24.42 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | — | — | — | 0.07 | 0.07 | — |
Average Payables |
3.10 | 3.51 | 1.51 | 1.36 | 0.81 | 0.38 | 0.38 | — |
Average Assets |
180.91 | 274.56 | 253.36 | 213.46 | 137.38 | 25.88 | 3.66 | — |
Average Common Equity |
126.12 | 224.39 | 227.87 | 206.98 | 103.30 | (15.01) | (15.01) | — |
Columns are period end dates